BeiGene Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
BeiGene, Ltd. (BGNE) PT Lowered to $215 at Maxim Group
August 9, 2018 12:39 PM EDTMaxim Group lowered its price target on BeiGene, Ltd. (NASDAQ: BGNE) to $215.00 (from $225.00) while maintaining a Buy rating.
... More